Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about recent data from ASCO 2025.
Dr. Raajit K. Rampal
Advertisement
Articles by Dr. Raajit K. Rampal
Advertisement
Latest Updated Articles
What Patients With Polycythemia Vera Should Know After ASCO 2025Published: June 21st 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
New Strategy May Prevent Breast Cancer Relapse
2
FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care
3
Understanding the Evolving Role of a Pathologist in Lung Cancer Care
4
All FDA Oncology Approvals From September 2025
5
